Literature DB >> 2839708

Unique requirement for the PyF441 mutation for polyomavirus infection of F9 embryonal carcinoma cells.

R W Tseng1, T Williams, F K Fujimura.   

Abstract

A point mutation at nucleotide 5258 in the enhancer of the polyomavirus host range mutant F441 permits productive infection of F9 embryonal carcinoma cells, which, when undifferentiated, are refractory to infection by wild-type polyomavirus. Synthetic oligonucleotides were used to construct viral genomes containing all four possible nucleotide pairs at nucleotide 5258. While all four of the viruses infected 3T6 cells efficiently, only F441, which has a guanosine in place of the wild-type adenosine in the early strand of DNA at position 5258, was able to infect F9 cells. Transfection assays with enhancer-dependent plasmid constructs expressing the chloramphenicol acetyltransferase gene under the control of the polyomavirus early promoter verified that only the F441 enhancer had any significant activity in F9 cells. DNase I footprinting showed that the F441 mutation creates a strong binding site for purified CCAAT box transcription factor, which is identical to nuclear factor 1. The three other mutations at nucleotide 5258 alter the affinity and the quality of factor binding at this site.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2839708      PMCID: PMC253727          DOI: 10.1128/JVI.62.8.2896-2902.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Polyoma virus DNA replication requires an enhancer.

Authors:  J de Villiers; W Schaffner; C Tyndall; S Lupton; R Kamen
Journal:  Nature       Date:  1984 Nov 15-21       Impact factor: 49.962

2.  Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma.

Authors:  P Herbomel; B Bourachot; M Yaniv
Journal:  Cell       Date:  1984-12       Impact factor: 41.582

3.  DNA fragments from F9 PyEC mutants increase expression of heterologous genes in transfected F9 cells.

Authors:  E Linney; S Donerly
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

4.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

5.  Supercoil sequencing: a fast and simple method for sequencing plasmid DNA.

Authors:  E Y Chen; P H Seeburg
Journal:  DNA       Date:  1985-04

6.  Multiple point mutations affecting the simian virus 40 enhancer.

Authors:  H Weiher; M König; P Gruss
Journal:  Science       Date:  1983-02-11       Impact factor: 47.728

7.  Oligonucleotide-directed mutagenesis: a simple method using two oligonucleotide primers and a single-stranded DNA template.

Authors:  M J Zoller; M Smith
Journal:  DNA       Date:  1984-12

8.  Polyomavirus origin for DNA replication comprises multiple genetic elements.

Authors:  W J Muller; C R Mueller; A M Mes; J A Hassell
Journal:  J Virol       Date:  1983-09       Impact factor: 5.103

9.  Bovine papilloma virus contains an activator of gene expression at the distal end of the early transcription unit.

Authors:  M Lusky; L Berg; H Weiher; M Botchan
Journal:  Mol Cell Biol       Date:  1983-06       Impact factor: 4.272

10.  Isolation and characterization of polyoma virus mutants which grow in murine embryonal carcinoma and trophoblast cells.

Authors:  K Tanaka; K Chowdhury; K S Chang; M Israel; Y Ito
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

View more
  7 in total

1.  Multiple domains in the polyomavirus B enhancer are required for productive infection of F9 embryonal carcinoma cells.

Authors:  R W Tseng; F K Fujimura
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

2.  Stimulation of BK virus DNA replication by NFI family transcription factors.

Authors:  Bo Liang; Irina Tikhanovich; Heinz Peter Nasheuer; William R Folk
Journal:  J Virol       Date:  2011-12-28       Impact factor: 5.103

3.  Mutations of polyomavirus VP1 allow in vitro growth in undifferentiated cells and modify in vivo tissue replication specificity.

Authors:  B Mezes; P Amati
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

4.  Mutations in the VP1 coding region of polyomavirus determine differentiating stage specificity.

Authors:  L Ricci; R Maione; C Passananti; A Felsani; P Amati
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

5.  Aphidicolin-resistant polyomavirus and subgenomic cellular DNA synthesis occur early in the differentiation of cultured myoblasts to myotubes.

Authors:  N J DePolo; L P Villarreal
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

6.  Evidence for a stem cell-specific repressor of Moloney murine leukemia virus expression in embryonal carcinoma cells.

Authors:  T P Loh; L L Sievert; R W Scott
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

Review 7.  RNA processing in the polyoma virus life cycle.

Authors:  Yingqun Huang; Gordon G Carmichael
Journal:  Front Biosci (Landmark Ed)       Date:  2009-06-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.